Assertio to Be Acquired by Garda Therapeutics in Strategic Agreement
Assertio to Be Acquired by Garda Therapeutics in $125.1 Million All-Cash Deal Assertio Holdings, Inc. has announced a definitive agreement to be acquired by Garda Therapeutics in an all-cash transaction valued at approximately $125.1 million, marking the culmination of a…
Healthpeak Properties to Announce Q1 2026 Results with Conference Call and Webcast
Healthpeak Properties, Inc. Announces Q1 2026 Earnings Release and Investor Call Details Healthpeak Properties, Inc., a prominent real estate investment trust (REIT) specializing in properties that support healthcare discovery and delivery, has officially announced the schedule for its first quarter…
Swisslog Healthcare Hosts Manufacturing Sector Partnership Meeting to Strengthen Regional Collaboration
Swisslog Healthcare Welcomes Boulder Chamber Manufacturing Group to Its Facility Swisslog Healthcare, a leading provider of pharmacy and transport automation solutions, recently hosted the Boulder Area Manufacturing Sector Partnership’s first quarterly meeting of 2026 at its Broomfield facility. The event…
Compass Pathways plc Announces Attendance at Needham Virtual Healthcare Conference
Compass Pathways plc Confirms Participation in Needham Virtual Healthcare Conference 2026 Compass Pathways plc has announced its participation in an upcoming major investor-focused healthcare event, underscoring its continued commitment to engaging with the financial community and increasing awareness of its…
Veradigm Names Christian Greyenbuhl as New Chief Financial Officer
Veradigm Strengthens Leadership with Appointment of Christian Greyenbuhl as Chief Financial Officer Veradigm Inc. (OTCMKTS: MDRX), a prominent provider of clinical, financial, and data-driven solutions designed to support independent healthcare practices, has announced the appointment of Christian Greyenbuhl as its…
Endospan Secures FDA Approval for NEXUS® Aortic Arch Stent Graft System
Endospan achieves FDA Approval for NEXUS® Aortic Arch Stent Graft System, Expanding Minimally Invasive Options for High-Risk Patients Endospan, a privately held medical device company based in Tel Aviv, Israel, has reached a significant regulatory milestone with the approval of…
Systane Named Official Eye Drop Partner of Toronto Blue Jays to Boost Dry Eye Awareness in Canada
Systane Partners with Toronto Blue Jays to Spotlight Dry Eye Awareness in Canada In a move that blends healthcare awareness with the excitement of professional sports, Alcon has announced a new partnership between its leading eye care brand Systane® and…
GenSight Biologics Announces Q1 2026 Cash Position and Early Access Revenue
GenSight Biologics Reports Q1 2026 Cash Position and Early Access Program Revenue Update GenSight Biologics, a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapies targeting retinal neurodegenerative diseases and central nervous system disorders, has reported its…
InterVene Hits Milestone with First 30 Recana® Thrombectomy Cases, Eyes Wider Commercial Launch
InterVene Reaches Key Milestone with 30 Procedures Using Recana Thrombectomy System InterVene, Inc., a privately held medical device company focused on advancing interventional solutions for venous disease, has announced a significant clinical milestone: the successful completion of 30 procedures using…
Stoke Therapeutics Appoints Clare Kahn, Ph.D., as Board Member
Stoke Therapeutics Strengthens Board with Appointment of Dr. Clare Kahn Stoke Therapeutics, Inc., a biotechnology company focused on transforming the treatment landscape for genetic diseases, has announced the appointment of Clare Kahn, Ph.D., to its Board of Directors. The addition…
Latent Bags $80M to Close Care Gap Between Diagnosis and Treatment
Latent Raises $80M Series A to Transform the Path from Diagnosis to Treatment Latent, a clinical AI company focused on accelerating access to life-saving medications, has announced the successful close of an $80 million Series A funding round. The round…
ForSight Robotics Achieves First-Ever Fully Robot-Assisted Cataract Surgery in Humans
ForSight Robotics Achieves Historic First-in-Human Fully Robot-Assisted Cataract Surgery ForSight Robotics has announced a historic milestone in the evolution of eye care: the successful completion of the world’s first fully robot-assisted cataract surgery performed on a human patient. Conducted using…